NCT00256308View on ClinicalTrials.gov

Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

May 31, 2010

Study Completion Date

October 31, 2011

Conditions
Head and Neck Cancer
Interventions
DRUG

Oxaliplatin

70mg/m2 IV over 120 min once a week during radiation

PROCEDURE

Radiation

200 cGy/day - Megavoltage equipment with energy of Cobalt 60 or higher - Daily from Monday to Friday

Trial Locations (1)

92868

Chao Family Comprehensive Cancer Center, Orange

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

University of California, Irvine

OTHER